Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,309,866)	$ (14,621,750)	$ (9,326,825)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted		6,346,281	726,252
Disposal of assets		5,806
Depreciation and amortization		40,289	28,690
Change in fair value of stock-based compensation liability		1,741,919	2,180,659
Changes in operating assets and liabilities:
Prepaid expenses		79,791	(39,387)
Research and development tax rebate receivable		(50,882)	(122,218)
Other assets		28,878	(114,353)
Accounts payable		148,102	215,803
Payroll liabilities		(165,343)	(78,717)
Accrued expenses		48,398	(38,432)
Other current liabilities		(21,524)	50,543
Net cash used in operating activities		(6,420,035)	(6,517,985)
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment		(7,625)	(54,448)
Net cash used in investing activities		(7,625)	(54,448)
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from issuance of Series B convertible preferred stock and warrants, net of issuance costs			12,290,551
Proceeds from exercise of warrants		11,336,710
Net cash provided by financing activities		11,336,710	12,290,551
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		4,909,050	5,718,118
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE		10,490,493	7,272,469
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	12,990,587	15,399,543	12,990,587
SUPPLEMENTAL DISCLOSURES
Cash and cash equivalents	12,935,587	15,289,543	12,935,587
Restricted cash	55,000	110,000	55,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	12,990,587	15,399,543	12,990,587
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation		3,151,944
Amortization of commitment shares	$ 19,853		$ 59,556